Bacterial vaginosis Bacterial vaginosis metronidazole Nystatin Di-
Conditions
Interventions
Metronidazole 200 mg oral 2 tablets po tid 7 days,Combined drug(GYNECON) 1 tablet vaginal suppository hs 7 days
Experimental Drug,Experimental Drug
Metronidazole group,Combined Nystatin,
Di-
iodohydroxyquin and Benzalkonium Chloride group
Sponsors
Research affairs, Faculty of Medicine, Khon Kaen university
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: diagnosis of bacterial vaginosis age 18-60
Exclusion criteria
Exclusion criteria: Allergy to Metronidazole, GYNECON History of bleeding per vagina(unknown cause) within 3 months History of vaginal tablet use within 1 month History of vaginal douche within 48 hours History of sexual intercourse with no barrier within 24 hours History of sexual transmitted diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure rate of Bacterial vaginosis 14 days Amsel criteria | — |
Secondary
| Measure | Time frame |
|---|---|
| side effect of medicine 14 days, 42 days Amsel criteria,patient satisfaction 14 days questionnaires | — |
Countries
Thailand
Contacts
Public ContactWichinee Chooprasertsuk
Departmentof obstetrics and gynecology, Faculty of medicine, Srinagarind hospital, Khon Kaen Univers
Outcome results
None listed